Access to this article is restricted until 12 months after publication by request of the publisher.. Restriction lift date: 2019-01-30
Synthesis of novel quinine analogs and evaluation of their effects on Trypanosoma cruzi
No Thumbnail Available
Ceole, Ligia F.
Villamizar, Luz H.
Soares, Maurilio J.
O'Sullivan, Timothy P.
Future Science: Newlands Press
Aim: Chagas disease is a tropical disease caused by the hemoflagellate protozoan Trypanosoma cruzi. There is no vaccine for Chagas disease and available drugs (e.g., benznidazole) are effective only during the acute phase, displaying a variable curative activity in the established chronic form of the disease. New leads with high efficacy and better toxicity profiles are urgently required. Materials & methods: A library of novel quinine derivatives was synthesized using Heck chemistry and evaluated against the various developmental forms of T. cruzi. Results and Conclusion: Several novel quinine analogs with trypanocidal activity have been identified with the para-nitro-substituted derivative displaying a submicromolar IC50, which is 83-times lower than quinine and three-times lower than benznidazole. Transmission electron microscopy analysis demonstrated that these compounds induced a marked vacuolization of the kinetoplast of intracellular amastigotes and cell-derived trypomastigotes.
Chagas disease , Heck coupling , Kinetoplast vacuolization , Quinine , Trypanocides , Trypanosoma cruzi , Ultrastructure
Ceole, L. F., Gandhi, H., Villamizar, L. H., Soares, M. J. and O'Sullivan, T. P. (2018) 'Synthesis of novel quinine analogs and evaluation of their effects on Trypanosoma cruzi', Future Medicinal Chemistry, 10(4), pp. 391-408. doi: 10.4155/fmc-2017-0184
© 2018 Newlands Press. For full bibliographic citation, please refer to the version available at www.future-science.com